Fbae Logo
Home | | Support Us | Contact Us
Goals & Objectives Our Position False Propaganda Special Topics Important Publications Important Links Events news Biosafety
Fbae Header Home

NEWS

 

 

 

Scientists Clone, Bureaucrats Clown

Henry I. Miller
 
After six years of deliberation, in January 2008, the Food and Drug Administration finally—and rightly—concluded that food from cloned animals is safe and may be sold and consumed. This decision was based on voluminous and incontrovertible scientific data. But two things took the luster off the announcement.

First, it was far too long in coming. Scientists have known for years that the clones are indistinguishable genetically, biochemically, and nutritionally from the parent.

Second, on the very day that the decision was announced, another federal agency attempted to undo the positive effects of FDA’s proclamation.

While not quibbling with the consensus about safety, Bruce I. Knight, Under Secretary for Marketing and Regulatory Programs with the U.S. Dept. of Agriculture, called for an indefinite continuation of the existing “voluntary moratorium” on the marketing of cloned animals and their offspring. He said that, “given the emotional nature of this issue,” U.S. and foreign consumers will need “an acceptance process” for the next few years.

This could represent a new nadir in bureaucratic reasoning and the sort of stunning debacle that makes policy wonks wonder—not for the first time—whether anyone is actually in charge of federal agencies’ decision-making. Where is the decider-in-chief when we need him?

My advice to Knight is to worry less about the emotions of consumers and more about the importance of permitting new, innovative technologies to provide safer, cheaper, and more nutritious food. Why not simply let the market place decide the viability and demand for these demonstrably safe products?

Cloning technology of one sort or another is widely applied to a variety of foods that we consume routinely and uncontroversially. As the journal Nature Biotechnology observed in a January 2007 editorial: “The irony in all this is that food from clones has been a part of our diet for years. Many common fruits (e.g., pears, apples, oranges and lemons) and several vegetables (e.g., potatoes and truffles) are clones. And most of us have probably ingested meat and dairy products from livestock cloned by natural reproduction (monozygotic siblings), mechanical embryo-splitting, or even nuclear transfer from an embryonic donor cell into an enucleated oocyte. Regulators traditionally paid scant attention to clones as a group—and rightly so.”

The animal clones that were the subject of FDA’s risk assessment are produced by taking a single cell from an animal that one wants to replicate and fusing it with a cow egg that has had its DNA removed. Then, a small electric shock induces the egg to grow into a copy of the original animal, resulting in the creation of an embryo that can be transferred to and gestated in a surrogate mother animal. The newborn is a replica of the animal that donated the initial cell. As one farmer who owns a pair of clones of a prize-winning Holstein cow observed, they are essentially twins of “a cow that was already in production.” Farmers want copies of exemplary animals.

Certain sectors of the food industry have expressed fears that consumers might reject milk and meat from cloned cows, but history argues otherwise.

Twenty years ago, there were similar concerns when dairy farmers began using a protein called bovine somatotropin, or bST, to stimulate milk production in cows; some analysts predicted that its introduction would so frighten consumers that milk consumption could drop as much as 20%. Although the milk is in no way different or less wholesome than that obtained from untreated cows, activists demanded special regulations, including mandatory labeling of dairy products from bST-treated animals. FDA demurred; the product was hugely successful; and a decade after milk from bST-treated cows began to be marketed, an analysis from the USDA’s Economic Research Service concluded: “Scientific evidence about food safety will not prevent controversy… Even intense controversy may have minimal or no effect on total demand [and] the absence of reports of harm from consumption contributes to continued consumption.”

The bST experience serves as a reminder that the mere presence of controversy—or pseudo-controversy generated by anti-technology activists and bureaucrats—should not cause industry or government regulators to overreact.

Cloning technology offers yet another tool for animal breeders to make foods cheaper and more consistent, nutritious, and tasty—if the know-nothing bureaucrats can be held at bay.

The producers of clones have waited too long and should push ahead without further delay.
 
Henry I. Miller, M.D., who headed the FDA’s Office of Biotechnology from 1989–1993, is a physician and Fellow at the Hoover Institution, StanfordUniversity, Stanford, CA94305 (miller@hoover.stanford.edu).
 
Related News Articles
 

Influence of Transgenosis on the Plant-Insect- Relationships, in Particular on Chemically       Mediated Interactions

Effect of Transgenes Conferring Enhanced Pathogen Resistance on the Interaction with Symbiotic        Fungi in Rice

Impact on the Soil Ecosystem through Natural and Genetically Engineered Organisms:
      Effects, Methods and Definition of Damage as Contribution to Risk Assessment

The Decomposition of Bt-Corn on the Fields and its Impact on Earthworms and on other        Macroorganisms in the Soil

Environmental Post-market Monitoring of Bt-maize:
       Approaches to Detect Potential Effects on Butterflies and Natural Enemies

Columns by Dan Gardner

Against the Grains: 'The Terminator Hoax '

Decisions taken in the 84th Meeting of the Genetic Engineering Approval Committee

Brazilian Health Biotech: Fostering Crosstalk Between Public and Private Sectors

Biotechnology Related Article Appeared on 'Samyukta Karnataka' ( Regional Language )
S.B.Sulia
June 12, 2008.

Nothing Left to the Imagination

The Politics of GM Food
Kirit S Javali

Hi-tech seed factories: Sowing Seeds of Success

"Indian Seed Industry is Well Placed to Serve Both Domestic and International Markets"
Dr MK Sharma,
Managing Director,
Mahyco Monsanto

"If we Facilitate Seed Industry, we Facilitate Growth in Agriculture"
Dr Govind Garg,
Director,
R&D,
Krishidhan Seeds

Metagenomics: Window to the Microbial Universe

Few Checks to Prevent Entry of GM Food

Gene Campaign Criticises India’s ‘Silence’ at Global Bio-Safety Meet

An Enforceable International Compact for Infectious Diseases

"Indian Science in Genomics has been Able to Place Itself on the Global Map"

Indian Gene Decoded

The Development of RNAi as a Therapeutic Strategy

FAO E-Conference on Biotechnologies and Water Scarcity

Genetic Landscape

Biotechnology in Food and Agriculture

RH Nature Reviews Genetics 08- Opposition to Transgenic Technologies


Germany: Discussion Paper of German Ag-Industry about EU Biotech Policy Implications


Bt maize performance in Spain

Arsenic speciation varies with type of rice

Why I Am Bothered by Neo-Colonialist NGOs

China experts identify gene for yield, height in rice

The French government has called for a debate on the review of the EU
The World Trade Organisation (WTO) has also repeatedly criticised the EU for "undue delays" in the authorisation of GMOs. See the latest WTO ruling:

The legal bans are in France, Austria, Poland, Hungary and Greece.

EU delays decision on approving more GM crops

UCR Geneticist Plays Scientific Advisor to Movie about “Love, Adventure and ... Genetically Modified Rice”

Gujrat worst-hit by illegal Bt cotton production

Farmers seek ban on GM crops

Call for policing
Ijaz Ahmed Rao discusses the virtues of a bio-safety framework for genetically modified crops, now that they have become farmers’ favourite


Stem cells: The 3-billion-dollar question


Genes as the solution

Food crisis spurs research spending


Global Food Crisis / UN / Bilingual Transcript of Statements by Secretary-General, Heads of Concerned Agencies, and Response to Questions at Press Conference on Global Food CrisisGM Crops, A World View

Mass Protests against GM Crops in IndiaInterference at the EPA

Open letter to Robert B. Zoellick, President, World BankNew BT variety may push short staple cotton output.

The future of agricultural biotechnology: Creative, destruction, adoption, or irrelevance? ICABR Conference 2008

Soaring food prices and global grain shortages are bringing new pressures on governments, food companies and consumers to relax their longstanding resistance to genetically engineered crops.


Prof. Kameswara Rao and Dr. T.M. Manjunath's Participation in 2008 Biotech Activities

Scrutinizing Industry-Funded Science: The Crusade Against Conflicts of Interest

LEADER: Nurturing nanotech


Center for Indigenous Knowledge for Agriculture and Rural Development


Scientists find potential schistosomiasis treatment

Islamic conference boosts S&T with new resolutions

Mexico publishes GM approval guidelines


Uganda 'close to stamping out Hib meningitis'


New method 'prevents spread of GM plants'


Social factors 'help women with post-tsunami stress'


Women scientists celebrated in new charter


Sub-Saharan Africa news in brief: 13–25 March

Brazil creates US$18 million fund for young scientists


Health weeks 'powerful tools' for deworming children


Rotavirus vaccine, not treatment, 'cheaper for Panama'